- Analysts provider for the pharmaceutical industry Diaceutics said it expected to list on AIM this week with a market capitalisation of around £53m.

The has raised £17m through placing at 76p per share.

It was expected that admission would become effective at 8am on or around 21 March, with shares trading under the 'DXRX' ticker.

'Diaceutics was founded out of a desire to get more patients access to improved healthcare,' chief executive Peter Keeling said.

'We are giving patients a higher likelihood of getting better by supporting access to the right test to determine the right treatment at the right time.'

'This announcement today will help us in our mission to continue this great work.'

Story provided by